Cargando…
Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer
Estrogen receptor α (ERα) is a master driver of a vast majority of breast cancers. Breast cancer cells often develop resistance to endocrine therapy via restoration of the ERα activity through survival pathways. Thus identifying the epigenetic activator of ERα that can be targeted to block ERα gene...
Autores principales: | Yu, L, Liang, Y, Cao, X, Wang, X, Gao, H, Lin, S-Y, Schiff, R, Wang, X-S, Li, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436938/ https://www.ncbi.nlm.nih.gov/pubmed/27893709 http://dx.doi.org/10.1038/onc.2016.433 |
Ejemplares similares
-
Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas
por: Parris, T Z, et al.
Publicado: (2014) -
TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy
por: Zehender, Ariella, et al.
Publicado: (2021) -
Evaluating amplified rDNA restriction analysis assay for identification of bacterial communities
por: Sklarz, Menachem Y., et al.
Publicado: (2009) -
Interaction of the epigenetic integrator UHRF1 with the MYST domain of TIP60 inside the cell
por: Ashraf, Waseem, et al.
Publicado: (2017) -
Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma
por: Wang, Yong, et al.
Publicado: (2013)